- Home
- BHAT vs IBIO Comparison
BHAT vs IBIO Comparison
Compare BHAT & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- IBIO
- Stock Information
- Founded
- BHAT 2010
- IBIO 2008
- Country
- BHAT China
- IBIO United States
- Employees
- BHAT N/A
- IBIO N/A
- Industry
- BHAT Recreational Games/Products/Toys
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- IBIO Health Care
- Exchange
- BHAT Nasdaq
- IBIO Nasdaq
- Market Cap
- BHAT 10.3M
- IBIO 9.3M
- IPO Year
- BHAT 2019
- IBIO N/A
- Fundamental
- Price
- BHAT $1.88
- IBIO $0.80
- Analyst Decision
- BHAT
- IBIO Strong Buy
- Analyst Count
- BHAT 0
- IBIO 3
- Target Price
- BHAT N/A
- IBIO $4.87
- AVG Volume (30 Days)
- BHAT 142.6K
- IBIO 2.3M
- Earning Date
- BHAT 04-30-2025
- IBIO 05-02-2025
- Dividend Yield
- BHAT N/A
- IBIO N/A
- EPS Growth
- BHAT N/A
- IBIO N/A
- EPS
- BHAT N/A
- IBIO N/A
- Revenue
- BHAT $18,724,190.00
- IBIO $375,000.00
- Revenue This Year
- BHAT N/A
- IBIO $36.00
- Revenue Next Year
- BHAT N/A
- IBIO N/A
- P/E Ratio
- BHAT N/A
- IBIO N/A
- Revenue Growth
- BHAT N/A
- IBIO 650.00
- 52 Week Low
- BHAT $1.65
- IBIO $0.64
- 52 Week High
- BHAT $145.00
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- BHAT 41.13
- IBIO 28.44
- Support Level
- BHAT $1.78
- IBIO $0.70
- Resistance Level
- BHAT $2.00
- IBIO $0.82
- Average True Range (ATR)
- BHAT 0.15
- IBIO 0.13
- MACD
- BHAT 0.02
- IBIO 0.10
- Stochastic Oscillator
- BHAT 23.81
- IBIO 10.82
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.